Bellevue Group’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $17.2M | Sell |
|
|||||
|
2023
Q4 | $71.8M | Buy |
|
|||||
|
2023
Q3 | $60.5M | Sell |
|
|||||
|
2023
Q2 | $100M | Buy |
|
|||||
|
2023
Q1 | $81.4M | Buy |
|
|||||
|
2022
Q4 | $53M | Buy |
|
|||||
|
2022
Q3 | $31.6M | Sell |
|
|||||
|
2022
Q2 | $26.3M | Buy |
|
|||||
|
2022
Q1 | $44.4M | Buy |
|
|||||
|
2021
Q4 | $31.8M | Sell |
|
|||||
|
2021
Q3 | $42M | Hold |
|
|||||
|
2021
Q2 | $57.5M | Buy |
|
|||||
|
2021
Q1 | $53.9M | Sell |
|
|||||
|
2020
Q4 | $44.1M | Sell |
|
|||||
|
2020
Q3 | $38.5M | Sell |
|
|||||
|
2020
Q2 | $28.9M | Buy |
|
|||||
|
2020
Q1 | $22.6M | Buy |
|
|||||
|
2019
Q4 | $29.5M | Buy |
|
|||||
|
2019
Q3 | $12.2M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $13.9M | Buy |
|